Senseonics has begun human testing of Freedom, a CGM designed to eliminate the on-body transmitter, with COO Mukul Jain ...

Integra LifeSciences topped Q3 estimates, but a $2.1B refinancing at higher rates and rising leverage have BTIG maintaining a ...

Abbott CEO Robert Ford explains how LAA and diabetes pressures drove Q3 guidance cuts, and what's ahead for 2027 growth.

Following the premiere of You Can See Everything, a panel of women from the medtech industry unpacked the complicated, ...

The Secaucus, NJ-based company joins a long list of medtech and healthcare companies that have faced cyberattacks in 2026.

Labcorp is on a buying spree – building up its testing capabilities and its presence in hospital facilities. The Burlington, NC-based company said it entered into a definitive agreement to acquire ...

Edwards said FDA approval of Pascal Ace with capture clarity simplifies mitral TEER procedures for clinicians. Edwards Lifesciences reported that FDA has approved its Pascal Precision system for ...

Designing, testing, and certifying home healthcare devices for safe, reliable use beyond the clinical environment.

The medical device industry is entering a new chapter of risk — one shaped not by a single technology shift, but by the accumulation of software, AI, and increasingly autonomous systems inside ...

Successful micro-sensor integration is critical to designing devices that drive revolutionary medical innovations.

The move follows a wave of similar divestitures across medtech as companies streamline portfolios and sharpen focus on higher-growth segments.

Johnson & Johnson has launched an intravascular lithotripsy catheter that cuts a broad range of calcified coronary artery lesions in half the time compared with previous devices.